leisure time -WSS

leisure time

author：fashion 2025-09-29 19:59:57 - browse：28

Verve Therapeutics said Sunday that the first 10 people to receive a one-time treatment powered by a form of CRISPR called base editing showed reductions in bad cholesterol levels — study results that are preliminary but signal the potential for gene-editing treatments to benefit people with an inherited type of cardiovascular disease.

Three of the study participants treated with potentially therapeutic doses of the Verve drug, called VERVE-101, showed reductions in LDL-C levels of 39%, 48%, and 55%, respectively. The latter patient’s decline in so-called “bad” cholesterol was maintained for six months.

The Verve-101 study results were presented at the American Heart Association conference and are the first data in patients from a therapy that uses base editing to change individual letters of DNA. Verve licensed the base-editing technology from Beam Therapeutics.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Too many hospitalized Covid

hotspot

WSS

Ebola vaccine can save some who are already sick, per new study

Celiac disease study examines precisely how gluten triggers injury

Congress likely to miss an opportunity to fix drug shortages issue

Tome Biosciences co

Abbott's new heart device gets FDA advisory panel nod

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

entertainment

leisure time

hotspot

Heart attack and stroke risk calculators need revising

Why Eli Lilly’s earnings didn’t quite live up to the hype

Medical records are filled with copy

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

Alkermes shareholders re

Too many hospitalized Covid

How one medical school became remarkably diverse

Celiac disease study examines precisely how gluten triggers injury

Continuity nursing helped my family in our darkest PICU moments

Having children helps parents live longer, especially after age 80

knowledge

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Artificial intelligence use in health care faces greater scrutiny in 2024

Here’s what’s in the FDA plan to include pregnant women in clinical trials

STAT Boddities: What happens to the brain when we get scared?

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

hotspot

focus

hotspot

focus